Companies

The full US-listed biotech/pharma universe & their upcoming catalysts. · 982 companies · not financial advice

TWST

Twist Bioscience Corp

$5.9B

Next catalyst: 2026-08-03

ERAS

Erasca, Inc.

$5.9B

Oncology

Next catalyst: 2026-08-12

CURLD

Curaleaf Holdings, Inc.

$5.8B

Next catalyst: 2026-08-05

CURLF

Curaleaf Holdings, Inc.

$5.8B

Next catalyst: 2026-08-05

SRRK

Scholar Rock Holding Corp

$5.7B

Metabolic / Obesity

Next catalyst: 2026-08-06

DNTH

Dianthus Therapeutics, Inc. /DE/

$5.7B

Neurology

Next catalyst: 2026-08-06

AMRX

Amneal Pharmaceuticals, Inc.

$5.7B

CardiovascularRx 11

Next catalyst: 2026-07-30

ORKA

Oruka Therapeutics, Inc.

$5.5B

Immunology / Inflammation

Next catalyst: 2026-08-10

TVTX

Travere Therapeutics, Inc.

$5.1B

Rx 1

Next catalyst: 2026-08-06

INDV

Indivior Pharmaceuticals, Inc.

$4.9B

Rx 7

Next catalyst: 2026-08-04

DFTX

Definium Therapeutics, Inc.

$4.7B

Psychiatry / CNS

Next catalyst: 2026-07-30

MANE

Veradermics, Inc

$4.6B

Dermatology

Next catalyst: 2026-08-01 · PHASE2

CRSP

CRISPR Therapeutics AG

$4.5B

Oncology

Next catalyst: 2026-08-10

CELC

Celcuity Inc.

$4.3B

Next catalyst: 2026-08-13

VKTX

Viking Therapeutics, Inc.

$4.2B

Metabolic / Obesity

Next catalyst: 2026-07-29

ACAD

ACADIA PHARMACEUTICALS INC

$4.2B

Rx 4

Next catalyst: 2026-08-04

EWTX

Edgewise Therapeutics, Inc.

$4.1B

Nephrology

Next catalyst: 2026-08-06

PRTCY

PureTech Health plc

$4.0B

Next catalyst: 2026-08-27

TNGX

Tango Therapeutics, Inc.

$4.0B

Oncology

Next catalyst: 2026-08-05

DBVT

DBV Technologies S.A.

$3.9B

Next catalyst: 2026-07-29

CPRX

CATALYST PHARMACEUTICALS, INC.

$3.9B

Rx 4

Next catalyst: 2026-08-05

RCUS

Arcus Biosciences, Inc.

$3.8B

Oncology

Next catalyst: 2026-08-05

DNLI

Denali Therapeutics Inc.

$3.6B

Rx 1

Next catalyst: 2026-08-10

RLAY

Relay Therapeutics, Inc.

$3.6B

Oncology

Next catalyst: 2026-08-06

NAMS

NewAmsterdam Pharma Co N.V.

$3.6B

Next catalyst: 2026-08-05

ADPT

Adaptive Biotechnologies Corp

$3.6B

Next catalyst: 2026-07-29

OGN

Organon & Co.

$3.6B

Rx 56

Next catalyst: 2026-08-04

TLX

Telix Pharmaceuticals Ltd

$3.5B

TLPPF

Telix Pharmaceuticals Ltd

$3.5B

Rx 1

SCNI

Scinai Immunotherapeutics Ltd.

$3.5B

ARQT

Arcutis Biotherapeutics, Inc.

$3.4B

Immunology / Inflammation

Next catalyst: 2026-08-05

DYN

Dyne Therapeutics, Inc.

$3.3B

Next catalyst: 2026-07-27

ELVN

Enliven Therapeutics, Inc.

$3.2B

Oncology

Next catalyst: 2026-08-12

IDYA

IDEAYA Biosciences, Inc.

$3.0B

Next catalyst: 2026-08-10

RGC

Regencell Bioscience Holdings Ltd

$2.9B

MBX

MBX Biosciences, Inc.

$2.8B

Nephrology

Next catalyst: 2026-08-06

IRON

Disc Medicine, Inc.

$2.8B

Hematology

Next catalyst: 2026-08-06

XTLB

XTL BIOPHARMACEUTICALS LTD

$2.8B

Pain

CLDX

Celldex Therapeutics, Inc.

$2.7B

Oncology

Next catalyst: 2026-08-06

SUPN

SUPERNUS PHARMACEUTICALS, INC.

$2.7B

Rx 5

Next catalyst: 2026-08-04

RARE

Ultragenyx Pharmaceutical Inc.

$2.7B

Rx 2

Next catalyst: 2026-08-04

BEAM

Beam Therapeutics Inc.

$2.7B

Next catalyst: 2026-08-04

ATAI

AtaiBeckley Inc.

$2.6B

Psychiatry / CNS

Next catalyst: 2026-08-01 · PHASE2

GRTX

Galera Therapeutics, Inc.

$2.6B

KOD

Kodiak Sciences Inc.

$2.6B

Metabolic / Obesity

Next catalyst: 2026-08-01 · PHASE3

VERA

Vera Therapeutics, Inc.

$2.5B

Immunology / Inflammation

Next catalyst: 2026-08-04

QURE

uniQure N.V.

$2.5B

Next catalyst: 2026-07-29

IMNM

Immunome Inc.

$2.5B

Oncology

Next catalyst: 2026-08-06

PPBT

PURPLE BIOTECH LTD.

$2.5B

Rx 1

TRVI

Trevi Therapeutics, Inc.

$2.5B

Respiratory

Next catalyst: 2026-08-06

Ticker	Company	Area	Rx	Mkt cap	Next catalyst
TWST	Twist Bioscience Corp	—	—	$5.9B	2026-08-03
ERAS	Erasca, Inc.	Oncology	—	$5.9B	2026-08-12
CURLD	Curaleaf Holdings, Inc.	—	—	$5.8B	2026-08-05
CURLF	Curaleaf Holdings, Inc.	—	—	$5.8B	2026-08-05
SRRK	Scholar Rock Holding Corp	Metabolic / Obesity	—	$5.7B	2026-08-06
DNTH	Dianthus Therapeutics, Inc. /DE/	Neurology	—	$5.7B	2026-08-06
AMRX	Amneal Pharmaceuticals, Inc.	Cardiovascular	11	$5.7B	2026-07-30
ORKA	Oruka Therapeutics, Inc.	Immunology / Inflammation	—	$5.5B	2026-08-10
TVTX	Travere Therapeutics, Inc.	—	1	$5.1B	2026-08-06
INDV	Indivior Pharmaceuticals, Inc.	—	7	$4.9B	2026-08-04
DFTX	Definium Therapeutics, Inc.	Psychiatry / CNS	—	$4.7B	2026-07-30
MANE	Veradermics, Inc	Dermatology	—	$4.6B	2026-08-01 PHASE2
CRSP	CRISPR Therapeutics AG	Oncology	—	$4.5B	2026-08-10
CELC	Celcuity Inc.	—	—	$4.3B	2026-08-13
VKTX	Viking Therapeutics, Inc.	Metabolic / Obesity	—	$4.2B	2026-07-29
ACAD	ACADIA PHARMACEUTICALS INC	—	4	$4.2B	2026-08-04
EWTX	Edgewise Therapeutics, Inc.	Nephrology	—	$4.1B	2026-08-06
PRTCY	PureTech Health plc	—	—	$4.0B	2026-08-27
TNGX	Tango Therapeutics, Inc.	Oncology	—	$4.0B	2026-08-05
DBVT	DBV Technologies S.A.	—	—	$3.9B	2026-07-29
CPRX	CATALYST PHARMACEUTICALS, INC.	—	4	$3.9B	2026-08-05
RCUS	Arcus Biosciences, Inc.	Oncology	—	$3.8B	2026-08-05
DNLI	Denali Therapeutics Inc.	—	1	$3.6B	2026-08-10
RLAY	Relay Therapeutics, Inc.	Oncology	—	$3.6B	2026-08-06
NAMS	NewAmsterdam Pharma Co N.V.	—	—	$3.6B	2026-08-05
ADPT	Adaptive Biotechnologies Corp	—	—	$3.6B	2026-07-29
OGN	Organon & Co.	—	56	$3.6B	2026-08-04
TLX	Telix Pharmaceuticals Ltd	—	—	$3.5B	—
TLPPF	Telix Pharmaceuticals Ltd	—	1	$3.5B	—
SCNI	Scinai Immunotherapeutics Ltd.	—	—	$3.5B	—
ARQT	Arcutis Biotherapeutics, Inc.	Immunology / Inflammation	—	$3.4B	2026-08-05
DYN	Dyne Therapeutics, Inc.	—	—	$3.3B	2026-07-27
ELVN	Enliven Therapeutics, Inc.	Oncology	—	$3.2B	2026-08-12
IDYA	IDEAYA Biosciences, Inc.	—	—	$3.0B	2026-08-10
RGC	Regencell Bioscience Holdings Ltd	—	—	$2.9B	—
MBX	MBX Biosciences, Inc.	Nephrology	—	$2.8B	2026-08-06
IRON	Disc Medicine, Inc.	Hematology	—	$2.8B	2026-08-06
XTLB	XTL BIOPHARMACEUTICALS LTD	Pain	—	$2.8B	—
CLDX	Celldex Therapeutics, Inc.	Oncology	—	$2.7B	2026-08-06
SUPN	SUPERNUS PHARMACEUTICALS, INC.	—	5	$2.7B	2026-08-04
RARE	Ultragenyx Pharmaceutical Inc.	—	2	$2.7B	2026-08-04
BEAM	Beam Therapeutics Inc.	—	—	$2.7B	2026-08-04
ATAI	AtaiBeckley Inc.	Psychiatry / CNS	—	$2.6B	2026-08-01 PHASE2
GRTX	Galera Therapeutics, Inc.	—	—	$2.6B	—
KOD	Kodiak Sciences Inc.	Metabolic / Obesity	—	$2.6B	2026-08-01 PHASE3
VERA	Vera Therapeutics, Inc.	Immunology / Inflammation	—	$2.5B	2026-08-04
QURE	uniQure N.V.	—	—	$2.5B	2026-07-29
IMNM	Immunome Inc.	Oncology	—	$2.5B	2026-08-06
PPBT	PURPLE BIOTECH LTD.	—	1	$2.5B	—
TRVI	Trevi Therapeutics, Inc.	Respiratory	—	$2.5B	2026-08-06

Page 3 of 20 · 982 companies

← Prev Next →

🔒 Company analytics are Pro

Distress & runway scores, analyst ratings, price-target upside, and short-squeeze (days-to-cover) across the whole universe — plus sorting and screening by them.

Upgrade to Pro